Paladin seeks over-the-counter MAP
Paladin Labs Inc., the Montreal-based Canadian distributor of the abortifacient morning-after pill. Plan B, announced that it has submitted an application to Health Canada to change Plan B, from prescription-only to non-prescription status. A Paladin press release noted that the Canadian Pharmacists Association and the Society of Obstetricians and Gynecologists of Canada collaberated on the submission. Campaign Life Coalition urged Health Canada [...]